Action against HIV drug resistance threat
Action against HIV drug resistance threat
Over the past decade, the world has witnessed an unprecedented increase in the use of antiretroviral therapy, which has saved the lives of tens of millions of people living with HIV/AIDS.Increased use of HIV medicines has been accompanied by the emergence of HIV drug resistance, the levels of which have steadily increased in recent years. As a result, many people find that their HIV medicines aren’t working due to resistance. The WHO Global Action Plan provides a framework for action for all stakeholders to monitor, prevent, and respond to HIV drug resistance. This includes five areas for joint action by global partners:
Improving prevention and response
Ensuring monitoring and surveillance
Supporting research and innovation;
Strengthening laboratory capacity; and
Reinforcing governance and enabling mechanisms.
More information: https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/hiv-drug-resistance/
Please, submit before 30 January 2022 your short film about HIV-AIDS in WHO's Health for All Film Festival: www.who.int/film-festival
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.